Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



Sale of Essure contraceptive device restricted by FDA

The US Food and Drug Administration (FDA) has taken steps to restrict the sale and distribution of the Essure device, citing the lack of awareness of the risks and benefits among many women opting for this form of contraception as one of its main concerns. “Based on our review of a growing...

Read More

FDA okays first drug therapy for rare inherited form of rickets

The US Food and Drug Administration (FDA) has approved Crysvita (burosumab) as a treatment for a rare form of inherited rickets. It is the first drug therapy approved as a treatment for x-linked hypophosphatemia (XLH) with evidence of bone disease in children over one year of age and adolescents...

Read More

NCHS: Adult obesity and diabetes on the rise in the United States

Obesity and diabetes are significantly more common in the United States than 20 years ago, according to recent data from the National Center for Health Statistics (NCHS). In 1997, under 20 percent of American adults over 20 years of age were classified as obese, a figure that rose to 31.4 percent...

Read More

Adcetris approved as treatment for classical Hodgkin lymphoma

The US Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) as a treatment for certain adult patients with classical Hodgkin lymphoma (cHL). Under the latest approval, the Seattle Genetics drug is indicated for use in combination with chemotherapy as a treatment for...

Read More

Outpatient pharmacy costs ‘higher at 340B hospitals’

Annual per patient outpatient pharmacy costs at hospitals participating in the 340B Drug Discount Program are significantly higher than in non-340B hospitals, according to new analysis from the Pharmaceutical Research and Manufacturers of America (PhRMA). The analysis, prepared by Milliman and...

Read More

Trogarzo approved as treatment option for patients with MDR HIV

A new treatment option is available for patients with multi-drug resistant (MDR) HIV following the US Food and Drug Administration’s (FDA) approval of Trogarzo (ibalizumab-uiyk). The medication, developed by TaiMed Biologics USA Corp, is a new form of antiretroviral medication indicated for...

Read More

Benefits of universal flu vaccination highlighted in new study

Universal vaccination against the flu could help slow the spread of the disease in the future, according to a recent study into the efficacy of flu vaccines. The clinical trial conducted by GlaxoSmithKline (GSK) examined the efficacy of Fluarix Tetra (inactivated quadrivalent influenza vaccine...

Read More